Florida / New York

Ph: 561.316.3330

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

The medical device space is growing rapidly as new startups and investments from major players enter the market. Some of the most notable investors in medical devices include venture capital firms such as Kleiner Perkins Caufield & Byers, Sequoia Capital, and Accel Partners, as well as large companies such as Johnson & Johnson and Medtronic.

This influx of investment is driving innovation in the medical device space, with new devices and treatments being developed all the time. This growth is also creating opportunities for entrepreneurs, who can now launch their own medical device startups and access funding from major players.

Accuray Announces First Patient Treatments in New Zealand With the CyberKnife ® System, the World’s Only Robotic Radiation Therapy Delivery Device

The ARO medical care team selected the latest generation CyberKnife S7 ™ System to provide stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) to patients more efficiently, minimizing the time they spend in daily treatments and maximizing the number of New Zealand cancer patients they can treat each day.

Read More »

SynerFuse Announces Solo Spine Surgeon Implants 8th Patient in Integrated Spinal Fusion and DRG Neuromodulation Proof-of-Concept Study

“So far in the study, the SynerFuse procedure has been efficient and straightforward to perform,” said Lall. “The industry has seen the efficacy of DRG stimulation for patients with chronic pain, and it is very exciting to be able to study incorporating it earlier in the treatment process for these patients in an attempt to reduce their pain levels and needs for opioids. I believe this will become widely adopted in spine surgery.”

Read More »
Fluidx Unveils New Embolic for Neurovascular Use
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

Fluidx Unveils New Embolic for Neurovascular Use

The IMPASS Embolic Device is part of the portfolio of embolics currently under development by Fluidx.  In the fall, Fluidx announced successful completion of a multi-center clinical trial with the GPX Embolic Device to treat a broad range of peripheral applications including tumor devascularization.

Read More »